Orr et al. [27] demonstrated that elevated nuclear immunoreactivity of YAP1 was prominent in high-grade gliomas, suggesting the potential role of YAP1 in the pathobiology of the most common malignant brain tumors. Here, YAP1 is linked to cancer.